Digital biomarkers in Clinical Trials

Digital biomarkers have the potential to form part of clinical research studies; while these can be used as endpoints in clinical trials, digital biomarkers can also be used to define inclusion/exclusion criteria, define treatment allocation arms, support dose selection or identify patients that should stop participating in the trial. However, even though ‘digital biomarkers’ has been a buzz word for a while now, there is still a lot of work to be done in regards to technical and clinical validation of digital biomarkers. Join us in this conversation with other senior leaders where we will discuss: